Cover image for Vol. 57 Issue 9

Edited By: Astrid Nehlig, PhD, Michael Sperling, MD. and Gary W. Mathern, MD.

Impact Factor: 4.706

ISI Journal Citation Reports © Ranking: 2015: 25/192 (Clinical Neurology)

Online ISSN: 1528-1167

Controversy in Epilepsy

Read varying viewpoints on controversial issues in the field of epilepsy

Addressing the important issues of the degree to which epileptic activity contributes to poorer developmental and cognitive outcomes above and beyond that which would be expected from the underlying etiology, which might influence treatment considerations.

The other side of epilepsy

Epileptic activity is a surrogate for an underlying etiology and stopping the activity has a limited impact on developmental outcome

Seizing control of epileptic activity can improve outcome

Epileptic encephalopathies: Optimizing seizure control and developmental outcome

Commentary: Should epileptiform discharges be treated?

Commentary: Obtaining genetic testing in pediatric epilepsy

Two sides of the argument are presented regarding the place of dietary treatments when standard anticonvulsant medications fail and surgery is not an option.

Commentary: Breaking down the barriers to using dietary therapy for refractory epilepsy

Dietary therapy is the best option for refractory nonsurgical epilepsy

Dietary therapy is not the best option for refractory nonsurgical epilepsy

Sudden unexpected death from epilepsy (SUDEP) has attracted considerable attention in the past several years, and there is increasing pressure from the epilepsy community to encourage medical professionals to tell their patients about it.

Sudden unexpected death in epilepsy: Assessing the public health burden

Characteristics of epilepsy patients and caregivers who either have or have not heard of SUDEP

Knowing the risk of SUDEP: Two family's perspectives and The Danny Did Foundation

Commentary: It's time to talk about SUDEP

The Asia versus Africa controversy stems from a sentence interpreted out of context, when addressing the cultural context of epilepsy in the African continent. Other communities in Asia and Latin America also have epilepsy embedded in their beliefs in similar ways.

Epilepsy: Asia versus Africa

Epilepsy is ubiquitous, but more devastating in the poorer regions of the world… or is it?

Commentary: Epilepsy is a Global Problem

Despite hundreds, if not thousands, of years of careful observation and documentation, as clinicians we still struggle to find accurate terminology for describing seizures and classifying types of epilepsy

Proposal: Different types of alteration and loss of consciousness in epilepsy

Consciousness as a useful concept in epilepsy classification

From the Editors: Using consciousness to describe seizures and classify the epilepsies

Commentary 1: Consciousness of Epilepsy

Commentary 2: Consciousness of Epilepsy

An important unresolved issue in the epidemiology of epilepsy is the unexplained difference between the accumulative incidence (adding up the number of new cases per year) and lifetime prevalence (number of people with epilepsy within a population). The possible reasons for this discrepancy are the subject of this month's Controversy in Epilepsy series

An unknown quantity—The worldwide prevalence of epilepsy

Prevalence of epilepsy—An unknown quantity

In this edition of Epilepsia, we present a series of articles on the potential use of CBD and medical marijuana for epilepsy. **See survey results from this Controversy series**

The case for assessing cannabidiol in epilepsy

The case for medical marijuana in epilepsy

Addressing the need for the Wada test (intracarotid amobarbital procedure, IAP) and extraoperative language and motor mapping in patients who are undergoing epilepsy surgery. The question: Can some or all of these tests be abandoned in favor of less-invasive and sometimes lower cost techniques?

Is it time to replace the Wada test and put awake craniotomy to sleep?

Cortical political maps cartography reveals physical and physical maps